Serum levels of C-peptide, IGFBP-1 and IGFBP-2 and endometrial cancer risk; Results from the European prospective investigation into cancer and nutrition
Open Access
- 10 April 2007
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 120 (12), 2656-2664
- https://doi.org/10.1002/ijc.22578
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Serum C‐peptide levels and breast cancer risk: Results from the European prospective investigation into cancer and nutrition (EPIC)International Journal of Cancer, 2006
- Association between Components of the Insulin-Like Growth Factor System and Endometrial Cancer RiskOncology, 2004
- Overweight, obesity and cancer: epidemiological evidence and proposed mechanismsNature Reviews Cancer, 2004
- Serum levels of insulin-like growth factor-I, IGF-binding protein 1 and 3, and insulin and endometrial cancer riskBritish Journal of Cancer, 2003
- Prediagnostic levels of C‐peptide, IGF‐I, IGFBP ‐1, ‐2 and ‐3 and risk of endometrial cancerInternational Journal of Cancer, 2003
- Physical activity of subjects aged 50–64 years involved in the European Prospective Investigation into Cancer and Nutrition (EPIC)Public Health Nutrition, 2002
- European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collectionPublic Health Nutrition, 2002
- Role of the Insulin-Like Growth Factor Family in Cancer Development and ProgressionJNCI Journal of the National Cancer Institute, 2000
- Increased Circulating Levels of Insulin-Like Growth Factor-I and Decreased Circulating Levels of Insulin-Like Growth Factor Binding Protein-1 in Postmenopausal Women with Endometrial Cancer.Endocrine Journal, 1997
- The dose-effect relationship between 'unopposed' oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer riskBritish Journal of Cancer, 1988